- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.02. | Sanofi announces positive results for venglustat in type 3 Gaucher disease | ||
| 12.02. | Putting AI to work for pharma marketing leaders of the future | ||
| 11.02. | Bayer launches 'Anything but Normal' campaign highlighting women's health issues | ||
| 11.02. | Designing healthcare AI that works for every patient | ||
| 11.02. | LEO Pharma's Anzupgo cream progresses to phase 3 trial for lichen sclerosus | ||
| 11.02. | ViCentra appoints Reman McDonagh as Vice President, Global Marketing | ||
| 10.02. | Novo Nordisk announces positive results for CagriSema in type 2 diabetes | ||
| 10.02. | TECregen appoints Klaas P Zuideveld as CEO | ||
| 10.02. | Shaping the future of healthcare communications | ||
| 09.02. | Celebrating Excellence in Healthcare Partnerships Awards! | ||
| 09.02. | Indegene appoints Jill DeSimone to Board of Directors | ||
| 09.02. | Oral health and systemic disease: why they may be more closely linked than we thought | ||
| 06.02. | Spyre Therapeutics appoints Kate Tansey Chevlen as Chief Commercial Officer | ||
| 06.02. | AstraZeneca and Daiichi Sankyo's Datroway given FDA Priority Review for breast cancer treatment | ||
| 06.02. | With compassion | ||
| 05.02. | UCB announces new positive data on Bimzelx in hidradenitis suppurativa | ||
| 05.02. | Sagimet announces positive results for Ascletis' denifanstat in moderate to severe acne | ||
| 05.02. | ASH 2025: where Magic Kingdom met the spirit of Andor | ||
| 04.02. | AstraZeneca's Imfinzi regimen receives positive CHMP opinion for early gastric and gastroesophageal cancer | ||
| 04.02. | Sanofi's Rezurock receives positive CHMP opinion for chronic graft-versus-host disease | ||
| 04.02. | McNamara's Fallacy | ||
| 03.02. | Johnson & Johnson's Darzalex Faspro regimen receives FDA approval for multiple myeloma | ||
| 03.02. | Biogen's litifilimab receives FDA Breakthrough Therapy Designation for lupus | ||
| 03.02. | Alzheimer's disease - the future of diagnosis and treatment in Europe | ||
| 02.02. | Boehringer Ingelheim and Simcere announce inflammatory bowel disease collaboration |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.